Mage Legal vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-21
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionMage LegalIsomorphic Labs
PricingContact for pricingContact for pricing
Best forM&A attorneys, in-house legal teams, PE deal teamsPharma companies, large drug development programs
Core technologyAI for document ingestion, disclosure schedules, cap table tie-outAlphaFold, predictive & generative AI for drug design
Target problemsAutomate M&A due diligence, reduce review weeks to daysAccelerate drug discovery, optimize lead molecules
Latest newsNo recent newsSeries B, J&J collaboration, $600M funding, new President & CMO, US ops
Not forSolo non-transactional lawyers, litigation, free-tier seekersIndividual researchers, small startups, no upfront pricing

Mage Legal and Isomorphic Labs operate in entirely different domains—M&A legal diligence vs. AI drug discovery. For corporate deal teams, Mage Legal is a turnkey due diligence automation platform with SOC 2 certification. For pharma R&D, Isomorphic Labs offers cutting-edge AlphaFold-based molecule design but only through deep partnerships. Choose based on your industry and scale; there is no direct overlap.

Mage Legal
Mage Legal

AI-powered M&A transactional diligence, from data room to closing.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
Popularity
5 views
7.4k views
Skill Level
Advanced
Advanced
API Available
Platforms
WebCLI
Categories
⚖️ Contracts, E-Signature & Legal
🧬 Drug Discovery & Life Sciences
Features
Automated disclosure schedule generation (e.g., Schedules 2.11(a), 3.4, 4.2, 2.7)
Counterparty markup review with keep/push-back recommendations
Scope Tabular view: resolves amendments, exhibits, side letters to document families
Cap table tie-out: links each issuance to its authorization
Variance detection across form agreements
Questionnaire and request list generation with answer tracking
Closing checklist generation with deliverable tracking
Privileged due diligence memorandum drafting
Committee and underwriting memo drafting
Company overview summarization of the target
Document ingestion from data room
Open-source CLI (MIT licensed, npm @magelegal/cli) for scripting data rooms
MCP server for AI agent operation (Claude, Cursor, etc.)
SOC 2 Type II certification
End-to-end coverage from data room to closing
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: Mage Legal vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Mage Legal

15 mentions across 1 sources · 50% positive — mixed

Lemmy

What users praise

  • Designed specifically for M&A diligence, not generic contract review.
  • Automates disclosure schedules, variance detection, and cap table tie-out.
  • SOC 2 Type II certified for security and data handling.
  • Generates privileged counsel memos and closing checklists automatically.

What frustrates them

  • No community reviews or testimonials available to validate claims.
  • Pricing is hidden behind 'contact us' — likely enterprise-level expensive.
  • No integrations with popular tools like Slack or Google Drive listed.
  • Limited to M&A transactions; not useful for other legal work.

Researched Jul 3, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • M&A Attorney at a mid-size law firm handling multiple deals per month
    Pick: Mage Legal

    Mage Legal automates disclosure schedules, cap table tie-out, and closing checklists, reducing hours per deal.

  • In-house legal team managing corporate development diligence for a PE firm
    Pick: Mage Legal

    Features like variance detection and counterparty markup review streamline due diligence across targets.

  • Large pharma company seeking AI-powered lead optimization for a late-stage pipeline
    Pick: Isomorphic Labs

    Isomorphic Labs' Drug Design Engine and partnership model (e.g., J&J collaboration) accelerate molecule design at scale.

  • Individual biotech researcher without pharma partnerships
    Pick: Isomorphic Labs

    Isomorphic Labs is not for individual use; consider other platforms like AlphaFold for research.

  • Solo practitioner handling non-transactional legal work
    Pick: Mage Legal

    Mage Legal is designed for M&A, not general contract review; it is not a fit.

Frequently Asked Questions

Mage Legal vs Isomorphic Labs: which should you choose?

Mage Legal and Isomorphic Labs operate in entirely different domains—M&A legal diligence vs. AI drug discovery. For corporate deal teams, Mage Legal is a turnkey due diligence automation platform with SOC 2 certification. For pharma R&D, Isomorphic Labs offers cutting-edge AlphaFold-based molecule design but only through deep partnerships. Choose based on your industry and scale; there is no direct overlap.

What is Mage Legal's primary use case?

Automating M&A transactional due diligence for law firms and corporate legal teams.

What is Isomorphic Labs' primary technology?

It uses AlphaFold and proprietary AI for drug discovery, focusing on protein-ligand interactions.

Can I purchase a standalone subscription to Isomorphic Labs?

No. It operates only through pharma partnerships; there is no retail software.

Does Mage Legal offer a free trial?

Pricing is contact-based; no public free tier mentioned.

Are these tools competitors?

No. Mage Legal is for legal M&A due diligence; Isomorphic Labs is for drug discovery.

What is the latest funding news for Isomorphic Labs?

Series B in Feb 2026; $600M external round in 2025.

Does Mage Legal integrate with data rooms?

Yes, it ingests documents directly from data rooms.

Which tool is SOC 2 certified?

Mage Legal is SOC 2 Type II certified.

More Mage Legal or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026